A clinical trial to study the efficacy of Rasa chendhuram internal drug for symmetrical multiple joints(Rheumatoid arthritis)

An open comparative clinical study on Udhira vadha suronitham Rheumatoid arthritis with the evaluation of siddha trial drugs Rasa chendhuram(int)Roga sanjeevi thylam(ext)Ottradam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008574

Enrollment

Registered

2017-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having arthritis of three or more joints pain and swelling in the distal interphalangeal joints morning stiffness patients having RAfactor positive Anti ccp positive and aneamia

Interventions

Intervention1: 1.Rasa chendhuram(Int) 2.Roga sanjeevi thylam(Ext): 1.20Patients treated with rasa chendhuram (int)-65mg twice daily with honey and Roga Sanjeevi thylam (ext) application for48days Int

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-60 Years Both male and female Morning stiffness Pain and swelling in the distal interphalangeal Joints. RA Factor positive ANTI CCP POSITIVE ARTHRITIS OF MORE THAN THREE JOINTS

Exclusion criteria

Exclusion criteria: Ankylosing Spondylitis Rheumatic fever Systemic lupus erythymatosus Gouty arthritis History of long term intake of steroids Osteomyelitis Pregnant women and lactatin mother

Design outcomes

Primary

Measure	Time frame
Reducing the pain and morning stiffnessTimepoint: 12 Months	—

Secondary

Measure	Time frame
To study the safety profile of the drug before and after treatment.Timepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr C ARUNA

Govt siddha medical college

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026